Pyrexar Medical
Medical Devices, 1825 W Research Way, Salt Lake City, Utah, 84119, United States, 11-50 Employees
Phone Number: 12*********
Who is PYREXAR MEDICAL
Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective hyperthermia treatment systems with established distribution...
Read More
-
Headquarters: 1825 W Research Way, Salt Lake City, Utah, 84119, United States
-
Date Founded: 2015
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3845
|
NAICS Code: 423450 |
Show More
Does something look wrong? Fix it. | View contact records from PYREXAR MEDICAL
Pyrexar Medical Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Pyrexar Medical
Answer: Pyrexar Medical's headquarters are located at 1825 W Research Way, Salt Lake City, Utah, 84119, United States
Answer: Pyrexar Medical's phone number is 12*********
Answer: Pyrexar Medical's official website is https://pyrexar.com
Answer: Pyrexar Medical's revenue is $5 Million to $10 Million
Answer: Pyrexar Medical's SIC: 3845
Answer: Pyrexar Medical's NAICS: 423450
Answer: Pyrexar Medical has 11-50 employees
Answer: Pyrexar Medical is in Medical Devices
Answer: Pyrexar Medical contact info: Phone number: 12********* Website: https://pyrexar.com
Answer: Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective hyperthermia treatment systems with established distribution and support networks in the US, Europe and Asia. PYREXAR Hyperthermia (PYREXAR HT) treatments increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity of healthy tissues. PYREXAR systems deliver therapeutic heating via non-invasive radio-frequency (RF) energy. During superficial, interstitial, or deep regional hyperthermia treatment, the cancerous tumor is gently warmed to 40-45 degrees C (104-113 degrees F) destroying malignant cells while preserving normal tissues because higher temperatures selectively damage cells that are hypoxic and have a low pH, a condition of cancer cells that is not present in normal cells. Multi-center clinical trials in the US, Europe and Asia over the past 30 years document dramatic improvement in survival rates when PYREXAR is combined with radiotherapy in the treatment of chest wall recurrences after breast cancer, locally advanced cervical cancer, high risk soft tissue sarcoma, melanoma and other malignancies. PYREXAR can now be integrated within 1.5 Tesla MR systems to provide simultaneous RF heating and MR Imaging, enabling investigation of treatments for deep primary tumors of pelvis, abdomen, and chest with real-time thermometry that is both highly accurate and non-invasive. This new multi-modality treatment approach has caused renewed interest in PYREXAR technology as a valuable adjunct to radiotherapy as well as chemotherapy and surgery. .
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month